跳至主要内容
临床试验/EUCTR2019-001539-29-DK
EUCTR2019-001539-29-DK进行中(未招募)1 期

Optimizing serum progesterone level during luteal phase in hormone replacement therapy frozen embryo transfer (HRT-FET) cycle – interventional and observational trial

The Fertility Clinic, Skive Regional Hospital0 个研究点目标入组 224 人开始时间: 2019年8月21日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
224

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • 18-45 years
  • BMI >18.5 <34 kg/m²
  • Blastocyst available for transfer after thawing
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 224
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Endometrium <7 mm after 12-20 days of 6 mg estradiol treatment.
  • Previous enrolment in the trial
  • No blastocyst for transfer
  • Uterine abnormalities
  • Oocyte donation
  • Dysregulated severe chronical medical diseases
  • Violation of the protocol

研究者

发起方
The Fertility Clinic, Skive Regional Hospital

相似试验